课题基金 / 基金详情

(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS

(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS
(PQ2) HIV 感染、APOBEC 上调和癌症突变
批准号:
9271943
负责人:
Reuben S Harris
金额:
$18.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-10 至 2018-04-30

项目摘要

项目成果

Reuben S Harris的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): The incidence of several types of cancer is higher in HIV-1 infected patients in comparison to the general population. Little is known about the mechanistic basis for these observations. This R21 proposal addresses RFA-CA-15-013 and, specifically, provocative question 2: "Other than immune dysfunction (including inflammation), what are the HIV-mediated mechanisms that underlie differential cancer risk in individuals with HIV infection?" We will use molecular virology and molecular biology approaches, together with bioinformatics, to investigate a mechanistic link between viral infection of CD4-positive T lymphocytes and a signaling mechanism that causes the trans-upregulation of antiviral APOBEC3 enzymes in bystander cells, leading to increased levels of genomic mutation that in turn result in a higher likelihood of cancer. The demonstration of such a mechanism would be a significant advance because it is novel and suggests multiple points for therapeutic intervention.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/ncomms12918
发表时间: 2016-09-21
期刊: NATURE COMMUNICATIONS
影响因子: 16.6
作者: [Starrett, Gabriel J., Luengas, Elizabeth M., McCann, Jennifer L., Ebrahimi, Diako, Temiz, Nuri A., Love, Robin P., Feng, Yuqing, Adolph, Madison B., Chelico, Linda, Law, Emily K., Carpenter, Michael A., Harris, Reuben S.]
通讯作者: Harris, Reuben S.
Midwest AViDD Center
  • 批准号:
    10631659
  • 项目类别:
  • 资助金额:
    $45.68万
  • 财政年份:
    2022
  • 负责人:
    Reuben S Harris
  • 依托单位:
Midwest AViDD Center
  • 批准号:
    10522804
  • 项目类别:
  • 资助金额:
    $6643.12万
  • 财政年份:
    2022
  • 负责人:
    Reuben S Harris
  • 依托单位:
Administrative-Core-001
Project 3: Pandemic Virus Protease Inhibitors
  • 批准号:
    10522812
  • 项目类别:
  • 资助金额:
    $288.0万
  • 财政年份:
    2022
  • 负责人:
    Reuben S Harris
  • 依托单位:
海外基金